Sanuwave Health (OTC:SNWV) said today it entered a memorandum of understanding with eKare to develop novel wound care analysis and management solutions which integrates technology from both companies. Through the deal, Sanuwave’s dermaPace wound treatment device will be linked with eKare’s inSight 3D wound imaging and analytics system to produce a comprehensive wound management solution, […]
Wound Care
Cytori launches next-gen Celution cell therapy tech
Cytori Therapeutics (NSDQ:CYTX) said today that the next-gen version of its Celution cell therapy device is available for pre-order and that the 1st shipments will start in the 3rd quarter of 2017. The San Diego-based company’s Celution system automates the extraction and concentration of autologous, clinical-grade adipose-derived regenerative cells. The next-gen Celution tech includes new […]
Acelity launches Prevena Duo NPWT system in US
Acelity said today it launched its Prevena Duo incision management system in the US. The Prevena Duo is a single use negative pressure wound therapy system specifically designed for the simultaneous management of 2 closed surgical incisions, the San Antonio, Texas-based company said, claiming it is the 1st such product of it’s kind. The system is designed […]
J&J’s Ethicon touts economic analysis data in Dermabond Prineo studies
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon today released the results from 2 economic analysis of its Dermabond Prineo skin closure system, touting improved patient outcomes and lower healthcare costs. The Dermabond Prineo skin closure system combines topical skin adhesive with a self-adhering patch, the company said. Data from the economic analyses of the system were presented […]
Hill-Rom launches Envella therapy bed for wound care patients
Hill-Rom Holdings (NYSE:HRC) said today it launched its Envella air fluidized therapy bed designed for wound care and patients with advanced wounds. The Envella bed was unveiled at the Wound Ostomy and Continence Nurses Society Annual Conference in Salt Lake City, Utah this week, the Chicago-based company said. Hill-Rom said that the Envella air fluidized therapy […]
New CollPlant division focuses on 3D bioprinting
Regenerative medicine company CollPlant said Thursday that it has created a new division to focus on collagen-based bioprinting. CollPlant has been utilizing its proprietary plant-based rhCollagen technology for tissue repair. The new division will further develop collagen-based bioink for use in 3D printers creating organs and tissues. The Ness Ziona, Israel–based company says it has 3D […]
Smith & Nephew gains as emerging markets boost Q1 results
Smith & Nephew (NYSE:SNN) shares are up today in London and New York after the British medical device giant said emerging markets drove strong 1st-quarter results. Overall sales grew 0.4% to $1.14 billion and 3% on a constant-currency basis for the 3 months ended April 1, the company said. Smith & Nephew no longer reports […]
7 medtech stories we missed this week: April 7, 2017
New studies for umbilical cord allografts and tumor targeting were published this week while another company received European CE Marking. Here are some medtech stories we missed this week but thought were still worth mentioning. 1. AMNIOX touts new umbilical cord study AMNIOX Medical announced that it has published the results of 3 studies that demonstrate […]
ETS Wound Care wins FDA nod for Mirragen wound matrix
ETS Wound Care said today it won FDA clearance for its Mirragen advanced wound matrix with indications for treating acute and chronic wounds. The Mirragen matrix is a fully resorbable borate glass matrix composed of fibers and beads which the Rolla, Mo.-based company claims is highly effective in wound care management. “Anyone who is treating […]
Integra, Dr. Reddy’s ink deal for DuraGen in India
Integra LifeSciences (NSDQ:IART) and Dr. Reddy’s Laboratories (NYSE:RDY) inked an exclusive distribution agreement for the DuraGen Plus and suturable DuraGen Dural Regeneration Matrices in India. According to the deal, Dr. Reddy’s will market and distribute the medical devices throughout India. The DuraGen Plus Dural Regeneration Matrix is indicated as a dural susbtitute for the repair of […]
Organogenesis launches PuraPly antimicrobial clinical program
Organogenesis said today that it launched its PuraPly Antimicrobial clinical research program, which will evaluate patients treated with PuraPly AM for up to 12 weeks. The 1st studies have started enrolling patients, according to Organogenesis. The Canton, Mass.-based company’s PuraPly AM is a 510(k)-cleared device indicated for the management of acute and chronic wounds. The […]